Superpower embeds in benefits at $179
Diving deeper into
Superpower
Superpower's October 2025 partnership with Thatch positions the platform within employer benefits at $179 annually, competing against subsidized offerings from established healthcare providers.
Analyzed 8 sources
Reviewing context
This partnership matters because it turns Superpower from a consumer wellness purchase into a benefits line item that can ride employer healthcare dollars. At $179 per year through Thatch, the product becomes cheap enough to fit inside HSA, FSA, and ICHRA workflows, which lowers the cash decision for employees and gives Superpower a bulk distribution channel instead of relying only on paid consumer acquisition.
-
Thatch is not just a referral partner. It provides the rails for employer funded health benefits, including HSA and ICHRA administration, plan selection, compliance, and carrier payments. That makes Superpower purchasable inside an existing employer benefits stack rather than as a separate app employees discover on their own.
-
The price point is the wedge. Function Health sells a $499 annual membership for two testing rounds, while Superpower lists annual testing around the low hundreds and charges $179 for each additional full panel on its consumer site. Employer access at $179 pushes Superpower closer to impulse benefit territory than premium concierge care.
-
The real competition is not only other startups, it is subsidized care from incumbents. Quest already sells consumer initiated testing, health coaching, employer population health programs, and sponsored testing partnerships. Large providers can bundle labs into insurance and employer arrangements in ways that make sticker price less visible to the end user.
The next step is a shift from one off testing to a recurring employer covered preventive care category. If Superpower can stay embedded in benefits platforms, it can win on convenience and budget fit, while larger incumbents keep pressing from the insurance side with broader subsidized offerings and deeper clinical networks.